Clinical
P
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Updates iPLEDGE REMS with New Modifications for Pregnancy Testing and Prescription Windows
2
Phase 3 Results Signal a New Era for Oral Targeted Therapy in Psoriasis
3
Tofacitinib Shows Promise in Omalizumab-Resistant CSU, New Case Series Finds
4
Raising the Bar for HS Outcomes With Barry Resnik, MD
5
